Stress Hastens Progression of Alzheimer's Disease - Study
Posted on: Wednesday, 30 August 2006, 15:00 CDT
Stress hormones appear to rapidly exacerbate the formation of brain lesions that are the hallmarks of Alzheimer's disease, according to researchers at UC Irvine.
The findings suggest that managing stress and reducing certain medications prescribed for the elderly could slow down the progression of this devastating disease.
In a study with genetically modified mice, Frank LaFerla, professor of neurobiology and behavior, and a team of UCI researchers found that when young animals were injected for just seven days with dexamethasone, a glucocorticoid similar to the body's stress hormones, the levels of the protein beta-amyloid in the brain increased by 60%.
When beta-amyloid production increases and these protein fragments aggregate, they form plaques, one of the two hallmark brain lesions of Alzheimer's disease.
The scientists also found that the levels of another protein, tau, also increased. Tau accumulation eventually leads to the formation of tangles, the other signature lesion of Alzheimer's. The findings appear in this week's issue of the Journal of Neuroscience.
"It is remarkable that these stress hormones can have such a significant effect in such a short period of time," LaFerla said. "Although we have known for some time that higher levels of stress hormones are seen in individuals in the early stages of Alzheimer's, this is the first time we have seen how these hormones play such a direct role in exacerbating the underlying pathology of the disease."
Source: Datamonitor
Related Articles
- Formal Education Lessens The Impact Of Alzheimer’s Disease
- Formal Education Lessens The Impact Of Alzheimer's Disease
- Avid Radiopharmaceuticals Presents Clinical Results of Novel Amyloid Imaging Agents at the 2008 International Conference on Alzheimer's Disease (ICAD)
- Light Used to Detect Alzheimer's Disease
- Anavex Advances Drug Candidate for Treatment of Alzheimer's Disease
- Eating Grapes May Protect Against Alzheimer's Disease
- Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients With Alzheimer's Disease?
- Searching for Methods to Detect, Prevent, and Treat Alzheimer's Disease
- TorreyPines Therapeutics Presents Data Showing Compounds Selectively Decrease Neurotoxic Amyloid Peptides Linked With Alzheimer's Disease
- Long-Term Effects of Rivastigmine Treatment on Neuropsychiatric and Behavioral Disturbances in Nursing Home Residents With Moderate to Severe Alzheimer's Disease: Results of a 52-Week Open-Label Study
User Comments (0)

RSS Feeds